Prostate Cancer Screening Second Edition
Prostate Cancer Screening Second Edition by Donna Pauler Ankerst, published by Humana Press on November 22, 2014, is a comprehensive resource that addresses the complexities of prostate cancer detection. This edition updates the first with the latest findings from leading experts, focusing on the current practices of prostate cancer screening worldwide. It covers the traditional PSA and DRE tests while also exploring advancements in biomarkers and risk algorithms, providing a thorough overview of the evolving landscape in prostate cancer screening.
Readers will find a collection of insightful contributions that delve into various aspects of prostate cancer detection, including family-based linkage analysis and potential challenges in evaluating biomarkers. The book serves as a valuable reference for urologists, oncologists, family physicians, and researchers in the biomarker field, aiming to enhance understanding and application of screening methods. With 397 pages of detailed information, this edition is designed to support medical professionals in navigating the complexities of prostate cancer screening and its implications in clinical practice.
Official synopsis Publisher
More than one in six men will develop prostate cancer in their lifetime. In recent years there has been an explosion of information regarding PSA screening and biomarkers for the disease. In Prostate Cancer Screening, Second Edition, the world’s leading experts on prostate cancer detection update the first edition with the latest findings. The book incorporates a series of thoughtful and cutting-edge works from the world’s experts in prostate cancer screening, ranging from the current status quo of prostate cancer screening across the globe to consensus on optimal utilization of the traditional PSA and DRE tests, to cutting-edge research in new biomarkers, biomeasures, and extended risk algorithms for prostate cancer. An additional chapter covers family-based linkage analysis as well as possible pitfalls in prostate cancer biomarker evaluation studies. Timely and authoritative, Prostate Cancer Screening, Second Edition, is an essential text for urologists, oncologists and family physicians, as well as researchers in the biomarker industry who seek methods to better develop and support markers and measures of prostate cancer.
Publisher
Topics
FAQ
What is “Prostate Cancer Screening Second Edition” about?
Who is the author of “Prostate Cancer Screening Second Edition”?
When was “Prostate Cancer Screening Second Edition” published?
What is the ISBN for “Prostate Cancer Screening Second Edition”?
What are the book details (language, pages, edition)?
